The rivaroxaban monotherapy group had a shorter hospitalization duration than that the standard therapy group, although this did not reach statistical significance.
← all excerpts
Efficacy and Safety of Rivaroxaban versus Warfarin for the Treatment of Acute Pulmonary Embolism: A Real-World Study.
1
—
—